Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection

被引:1095
作者
Zincarelli, Carmela [1 ]
Soltys, Stephen [1 ,2 ]
Rengo, Giuseppe [1 ,2 ]
Rabinowitz, Joseph E. [1 ]
机构
[1] Thomas Jefferson Univ, Ctr Translat Med, Dept Med, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Dept Med, George Zallie & Family Lab Cardiovasc Gene Therap, Philadelphia, PA 19107 USA
关键词
D O I
10.1038/mt.2008.76
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
This study examines transgene expression and biodistribution of adeno-associated virus ( AAV) pseudotyped 1-9 after tail vein ( TV) injection in male mice. Using a cytomegalovirus ( CMV)-luciferase transgene, the time-course of expression in each animal was tracked throughout the experiment. The animals were imaged at 7, 14, 29, 56, and 100 days after the TV injection. The total number of photons emitted from each animal was recorded, allowing examination of expression level and kinetics for each pseudotyped virus. The bioluminescence imaging revealed three expression levels ( i) low-expression group, AAV2, 3, 4, and 5; ( ii) moderate-expression group, AAV1, 6, and 8; and ( iii) high-expression group, AAV7 and 9. In addition, imaging revealed two classes of kinetics ( i) rapid-onset, for AAV1, 6, 7, 8, and 9; and ( ii) slow-onset, for AAV2, 3, 4, and 5. We next evaluated protein expression and viral genome copy numbers in dissected tissues. AAV9 had the best viral genome distribution and highest protein levels. The AAV7 protein and genome copy numbers were comparable to those of AAV9 in the liver. Most surprisingly, AAV4 showed the greatest number of genome copies in lung and kidney, and a high copy number in the heart. AAV6 expression was observed in the heart, liver, and skeletal muscle, and the genome distribution corroborated these observations.
引用
收藏
页码:1073 / 1080
页数:8
相关论文
共 41 条
[1]   Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors [J].
Bartlett, JS ;
Wilcher, R ;
Samulski, RJ .
JOURNAL OF VIROLOGY, 2000, 74 (06) :2777-2785
[2]   THE CRYPTIC LIFE-STYLE OF ADENOASSOCIATED VIRUS [J].
BERNS, KI ;
LINDEN, RM .
BIOESSAYS, 1995, 17 (03) :237-245
[3]   Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6 [J].
Blankinship, MJ ;
Gregorevic, P ;
Allen, JM ;
Harper, SQ ;
Harper, H ;
Halbert, CL ;
Miller, AD ;
Chamberlain, JS .
MOLECULAR THERAPY, 2004, 10 (04) :671-678
[4]   Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system [J].
Burger, C ;
Gorbatyuk, OS ;
Velardo, MJ ;
Peden, CS ;
Williams, P ;
Zolotukhin, S ;
Reier, PJ ;
Mandel, RJ ;
Muzyczka, N .
MOLECULAR THERAPY, 2004, 10 (02) :302-317
[5]   Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain [J].
Cearley, CN ;
Wolfe, JH .
MOLECULAR THERAPY, 2006, 13 (03) :528-537
[6]   Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors [J].
Chao, HJ ;
Liu, YB ;
Rabinowitz, J ;
Li, CW ;
Samulski, RJ ;
Walsh, CE .
MOLECULAR THERAPY, 2000, 2 (06) :619-623
[7]   Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles [J].
Chiorini, JA ;
Yang, L ;
Liu, YJ ;
Safer, B ;
Kotin, RM .
JOURNAL OF VIROLOGY, 1997, 71 (09) :6823-6833
[8]   Cloning and characterization of adeno-associated virus type 5 [J].
Chiorini, JA ;
Kim, F ;
Yang, L ;
Kotin, RM .
JOURNAL OF VIROLOGY, 1999, 73 (02) :1309-1319
[9]   Intracellular trafficking of adeno-associated virus vectors: Routing to the late endosomal compartment and proteasome degradation [J].
Douar, AM ;
Poulard, K ;
Stockholm, D ;
Danos, O .
JOURNAL OF VIROLOGY, 2001, 75 (04) :1824-1833
[10]   Dynamin is required for recombinant adeno-associated virus type 2 infection [J].
Duan, DS ;
Li, Q ;
Kao, AW ;
Yue, YP ;
Pessin, JE ;
Engelhardt, JF .
JOURNAL OF VIROLOGY, 1999, 73 (12) :10371-10376